Immuneering Corp
(NASDAQ:IMRX)
$7.54
-0.19[-2.46%]
Last update: 11:18AM (Delayed 15-Minutes)
Get Real Time Here
$7.73
0.1900[2.52%]
Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020

Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary

Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.

Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.530-0.430 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-08OppenheimerMark BreidenbachReiteratesOutperformOutperformMaintains-25.00
2023-08-07Chardan CapitalGeulah LivshitsReiteratesBuyBuyMaintains-22.00
2023-08-04Morgan StanleyJeffrey HungMaintainsEqual-WeightEqual-WeightMaintains14.0014.00
2023-06-26OppenheimerMark BreidenbachAssumesOutperformAnnounces-25.00

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering-2.46%220.7M
RENBRenovaro Biosciences-2.6%238.9M
IPHAInnate Pharma2.99%222.2M
CELCCelcuity-0.8%217.8M
EGRXEagle Pharmaceuticals3.48%204.7M
Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.

Q

Does Immuneering (IMRX) pay a dividend?

A

There is no dividend information for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary

Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.

Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.530-0.430 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-08OppenheimerMark BreidenbachReiteratesOutperformOutperformMaintains-25.00
2023-08-07Chardan CapitalGeulah LivshitsReiteratesBuyBuyMaintains-22.00
2023-08-04Morgan StanleyJeffrey HungMaintainsEqual-WeightEqual-WeightMaintains14.0014.00
2023-06-26OppenheimerMark BreidenbachAssumesOutperformAnnounces-25.00

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering-2.46%220.7M
RENBRenovaro Biosciences-2.6%238.9M
IPHAInnate Pharma2.99%222.2M
CELCCelcuity-0.8%217.8M
EGRXEagle Pharmaceuticals3.48%204.7M
Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.

Q

Does Immuneering (IMRX) pay a dividend?

A

There is no dividend information for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary

Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.

Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.530-0.430 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-08OppenheimerMark BreidenbachReiteratesOutperformOutperformMaintains-25.00
2023-08-07Chardan CapitalGeulah LivshitsReiteratesBuyBuyMaintains-22.00
2023-08-04Morgan StanleyJeffrey HungMaintainsEqual-WeightEqual-WeightMaintains14.0014.00
2023-06-26OppenheimerMark BreidenbachAssumesOutperformAnnounces-25.00

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering-2.46%220.7M
RENBRenovaro Biosciences-2.6%238.9M
IPHAInnate Pharma2.99%222.2M
CELCCelcuity-0.8%217.8M
EGRXEagle Pharmaceuticals3.48%204.7M
Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.

Q

Does Immuneering (IMRX) pay a dividend?

A

There is no dividend information for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary

Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.

Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.530-0.430 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-08OppenheimerMark BreidenbachReiteratesOutperformOutperformMaintains-25.00
2023-08-07Chardan CapitalGeulah LivshitsReiteratesBuyBuyMaintains-22.00
2023-08-04Morgan StanleyJeffrey HungMaintainsEqual-WeightEqual-WeightMaintains14.0014.00
2023-06-26OppenheimerMark BreidenbachAssumesOutperformAnnounces-25.00

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering-2.46%220.7M
RENBRenovaro Biosciences-2.6%238.9M
IPHAInnate Pharma2.99%222.2M
CELCCelcuity-0.8%217.8M
EGRXEagle Pharmaceuticals3.48%204.7M
Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.

Q

Does Immuneering (IMRX) pay a dividend?

A

There is no dividend information for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary

Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.

Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.530-0.430 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-08OppenheimerMark BreidenbachReiteratesOutperformOutperformMaintains-25.00
2023-08-07Chardan CapitalGeulah LivshitsReiteratesBuyBuyMaintains-22.00
2023-08-04Morgan StanleyJeffrey HungMaintainsEqual-WeightEqual-WeightMaintains14.0014.00
2023-06-26OppenheimerMark BreidenbachAssumesOutperformAnnounces-25.00

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering-2.46%220.7M
RENBRenovaro Biosciences-2.6%238.9M
IPHAInnate Pharma2.99%222.2M
CELCCelcuity-0.8%217.8M
EGRXEagle Pharmaceuticals3.48%204.7M
Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.

Q

Does Immuneering (IMRX) pay a dividend?

A

There is no dividend information for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary

Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.

Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.530-0.430 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-08OppenheimerMark BreidenbachReiteratesOutperformOutperformMaintains-25.00
2023-08-07Chardan CapitalGeulah LivshitsReiteratesBuyBuyMaintains-22.00
2023-08-04Morgan StanleyJeffrey HungMaintainsEqual-WeightEqual-WeightMaintains14.0014.00
2023-06-26OppenheimerMark BreidenbachAssumesOutperformAnnounces-25.00

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering-2.46%220.7M
RENBRenovaro Biosciences-2.6%238.9M
IPHAInnate Pharma2.99%222.2M
CELCCelcuity-0.8%217.8M
EGRXEagle Pharmaceuticals3.48%204.7M
Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.

Q

Does Immuneering (IMRX) pay a dividend?

A

There is no dividend information for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary

Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.

Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.530-0.430 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-08OppenheimerMark BreidenbachReiteratesOutperformOutperformMaintains-25.00
2023-08-07Chardan CapitalGeulah LivshitsReiteratesBuyBuyMaintains-22.00
2023-08-04Morgan StanleyJeffrey HungMaintainsEqual-WeightEqual-WeightMaintains14.0014.00
2023-06-26OppenheimerMark BreidenbachAssumesOutperformAnnounces-25.00

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering-2.46%220.7M
RENBRenovaro Biosciences-2.6%238.9M
IPHAInnate Pharma2.99%222.2M
CELCCelcuity-0.8%217.8M
EGRXEagle Pharmaceuticals3.48%204.7M
Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.

Q

Does Immuneering (IMRX) pay a dividend?

A

There is no dividend information for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary

Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.

Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.530-0.430 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-08OppenheimerMark BreidenbachReiteratesOutperformOutperformMaintains-25.00
2023-08-07Chardan CapitalGeulah LivshitsReiteratesBuyBuyMaintains-22.00
2023-08-04Morgan StanleyJeffrey HungMaintainsEqual-WeightEqual-WeightMaintains14.0014.00
2023-06-26OppenheimerMark BreidenbachAssumesOutperformAnnounces-25.00

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering-2.46%220.7M
RENBRenovaro Biosciences-2.6%238.9M
IPHAInnate Pharma2.99%222.2M
CELCCelcuity-0.8%217.8M
EGRXEagle Pharmaceuticals3.48%204.7M
Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.

Q

Does Immuneering (IMRX) pay a dividend?

A

There is no dividend information for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary

Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.

Open7.700Close-
Vol / Avg.6.847K / 97.184KMkt Cap220.651M
Day Range7.420 - 7.70052 Wk Range3.700 - 16.020
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.530-0.430 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-08OppenheimerMark BreidenbachReiteratesOutperformOutperformMaintains-25.00
2023-08-07Chardan CapitalGeulah LivshitsReiteratesBuyBuyMaintains-22.00
2023-08-04Morgan StanleyJeffrey HungMaintainsEqual-WeightEqual-WeightMaintains14.0014.00
2023-06-26OppenheimerMark BreidenbachAssumesOutperformAnnounces-25.00

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering-2.46%220.7M
RENBRenovaro Biosciences-2.6%238.9M
IPHAInnate Pharma2.99%222.2M
CELCCelcuity-0.8%217.8M
EGRXEagle Pharmaceuticals3.48%204.7M
Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Tuesday, August 8, 2023. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 231.56% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $7.54 last updated Today at September 22, 2023 at 3:18 PM UTC.

Q

Does Immuneering (IMRX) pay a dividend?

A

There is no dividend information for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.